Archive for February 2026

For years, “quality” in clinical research and regulated product development has had an identity problem. It was often confused with: If it felt like quality was something you survived rather than used, you weren’t wrong. Enter ICH GCP E6(R3) and the FDA’s Quality System Management Review (QSMR), two frameworks that quietly but decisively change the…